研究领域

肺癌、肺部感染等呼吸系统常见疾病诊治及基础研究

论文与著作

1.Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway.BMC CANCER.2024,24(1):408.（通讯作者）

2.Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis.Frontiers in Cardiovascular Medicine.2024,11:1381408.（通讯作者）

3.Association of interleukin-6, ferritin, and lactate dehydrogenase with venous thromboembolism in COVID-19: a systematic review and meta-analysis.BMC INFECTIOUS DISEASES.2024,24(1):324.（通讯作者）

4.Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors:A Meta-Analysis.J Clin Pharmacol. 2023,63(2):210-218. （通讯作者）

5.Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis.Cancer Med. 2023,12(4):4087-4099.（通讯作者）

6.Transcriptome dysregulation in hyper-progressive disease samples with immune checkpoint blockade.Chin Med J (Engl). 2023,136(24):3019-3021.（通讯作者）

7.ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway.Cancer Cell International. 2021,21(1):320（通讯作者）

8.A systematic review and meta-analysis of immune-mediated liver dysfunction in non-small cell lung cancer. Int Immunopharmacol. 2020,83(6):106537. （通讯作者）

荣誉与奖励

获得福建医学科技奖二等奖1项，福建医学科技奖三等奖3项，福建省科学技术进步奖1项。

获“福建五四青年奖章获得者”、“福建省三八红旗手”“及“福建省抗击新冠肺炎疫情先进个人”。

获福建医科大学“优秀教师”